PubMed

The effects of IgM-enriched immunoglobulin preparations in patients with severe sepsis [ISRCTN28863830].

Tugrul S, Ozcan PE, Akinci O, Seyhun Y, Cagatay A, Cakar N, Esen F.

Crit Care. 2002 Aug;6(4):357-62. Epub 2002 May 14.PMID: 12225613 [PubMed - indexed for MEDLINE]Related articlesFree article

[The effect of pentaglobin therapy on prognosis in patients with severe sepsis]

Tuğrul S, Ozcan PE, Akinci O, Cağatay A, Cakar N, Esen F.

Ulus Travma Derg. 2001 Oct;7(4):219-23. Turkish. PMID: 11705075 [PubMed - indexed for MEDLINE]Related articles

Clinical experience with polyclonal IgM-enriched immunoglobulins in a group of patients affected by sepsis after cardiac surgery.

Buda S, Riefolo A, Biscione R, Goretti E, Cattabriga I, Grillone G, Bacchi-Reggiani L, Pacini D.

J Cardiothorac Vasc Anesth. 2005 Aug;19(4):440-5.PMID: 16085247 [PubMed - indexed for MEDLINE]Related articles

Comparison of early IgM-enriched immunoglobulin vs polyvalent IgG administration in score-identified postcardiac surgical patients at high risk for sepsis.

Pilz G, Appel R, Kreuzer E, Werdan K.

Chest. 1997 Feb;111(2):419-26.PMID: 9041991 [PubMed - indexed for MEDLINE]Related articlesFree article

IgM-enriched immunoglobulin (pentaglobin) positively influences the course of post-surgical intra-abdominal infections.

Reith HB, Rauchschwalbe SK, Mittelkötter U, Engemann R, Thiede A, Arnold A, Lissner R.

Eur J Med Res. 2004 Oct 29;9(10):479-84.PMID: 15546815 [PubMed - indexed for MEDLINE]Related articles

Endotoxin concentration in neutropenic patients with suspected gram-negative sepsis: correlation with clinical outcome and determination of anti-endotoxin core antibodies during therapy with polyclonal immunoglobulin M-enriched immunoglobulins.

Behre G, Schedel I, Nentwig B, Wörmann B, Essink M, Hiddemann W.

Antimicrob Agents Chemother. 1992 Oct;36(10):2139-46.PMID: 1444293 [PubMed - indexed for MEDLINE]Related articlesFree article

p55 Tumor necrosis factor receptor fusion protein in the treatment of patients with severe sepsis and septic shock. A randomized controlled multicenter trial. Ro 45-2081 Study Group.

Abraham E, Glauser MP, Butler T, Garbino J, Gelmont D, Laterre PF, Kudsk K, Bruining HA, Otto C, Tobin E, Zwingelstein C, Lesslauer W, Leighton A.

JAMA. 1997 May 21;277(19):1531-8.PMID: 9153367 [PubMed - indexed for MEDLINE]Related articles

Cost-effectiveness of immunoglobulin M-enriched immunoglobulin (Pentaglobin) in the treatment of severe sepsis and septic shock.

Neilson AR, Burchardi H, Schneider H.

J Crit Care. 2005 Sep;20(3):239-49.PMID: 16253792 [PubMed - indexed for MEDLINE]Related articles

Effects of high-dose of intravenous immunoglobulin and antibiotics on survival for severe sepsis undergoing surgery.

Rodríguez A, Rello J, Neira J, Maskin B, Ceraso D, Vasta L, Palizas F.

Shock. 2005 Apr;23(4):298-304.PMID: 15803051 [PubMed - indexed for MEDLINE]Related articles

Use of IgM and IgA-enriched immunoglobulins in the treatment of severe sepsis and septic shock. Clinical experience.

Berlot G, Dimastromatteo G.

Minerva Anestesiol. 2004 Oct;70(10):739-43; 743-5. English, Italian. PMID: 15516885 [PubMed - indexed for MEDLINE]Related articlesFree article

Selenium in Intensive Care (SIC): results of a prospective randomized, placebo-controlled, multiple-center study in patients with severe systemic inflammatory response syndrome, sepsis, and septic shock.

Angstwurm MW, Engelmann L, Zimmermann T, Lehmann C, Spes CH, Abel P, Strauss R, Meier-Hellmann A, Insel R, Radke J, Schüttler J, Gärtner R.

Crit Care Med. 2007 Jan;35(1):118-26.PMID: 17095947 [PubMed - indexed for MEDLINE]Related articles

The clinical usefulness of procalcitonin measurement for assessing the severity of bacterial infection in critically ill patients requiring corticosteroid therapy.

Kushimoto S, Shibata Y, Koido Y, Kawai M, Yokota H, Yamamoto Y.

J Nippon Med Sch. 2007 Jun;74(3):236-40.PMID: 17625373 [PubMed - indexed for MEDLINE]Related articlesFree article

Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial.

Nobre V, Harbarth S, Graf JD, Rohner P, Pugin J.

Am J Respir Crit Care Med. 2008 Mar 1;177(5):498-505. Epub 2007 Dec 20.PMID: 18096708 [PubMed - indexed for MEDLINE]Related articlesFree article

Procalcitonin and C-reactive protein during systemic inflammatory response syndrome, sepsis and organ dysfunction.

Castelli GP, Pognani C, Meisner M, Stuani A, Bellomi D, Sgarbi L.

Crit Care. 2004 Aug;8(4):R234-42. Epub 2004 Jun 10.PMID: 15312223 [PubMed - indexed for MEDLINE]Related articlesFree article

Lenercept (p55 tumor necrosis factor receptor fusion protein) in severe sepsis and early septic shock: a randomized, double-blind, placebo-controlled, multicenter phase III trial with 1,342 patients.

Abraham E, Laterre PF, Garbino J, Pingleton S, Butler T, Dugernier T, Margolis B, Kudsk K, Zimmerli W, Anderson P, Reynaert M, Lew D, Lesslauer W, Passe S, Cooper P, Burdeska A, Modi M, Leighton A, Salgo M, Van der Auwera P; Lenercept Study Group.

Crit Care Med. 2001 Mar;29(3):503-10.PMID: 11373411 [PubMed - indexed for MEDLINE]Related articles

Plasma procalcitonin in sepsis and organ failure.

Yukioka H, Yoshida G, Kurita S, Kato N.

Ann Acad Med Singapore. 2001 Sep;30(5):528-31.PMID: 11603140 [PubMed - indexed for MEDLINE]Related articles

Effect of pentoxifylline in severe sepsis: results of a randomized, double-blind, placebo-controlled study.

Staubach KH, Schröder J, Stüber F, Gehrke K, Traumann E, Zabel P.

Arch Surg. 1998 Jan;133(1):94-100.PMID: 9438767 [PubMed - indexed for MEDLINE]Related articlesFree article

Can procalcitonin help us in timing of re-intervention in septic patients after multiple trauma or major surgery?

Svoboda P, Kantorová I, Scheer P, Radvanova J, Radvan M.

Hepatogastroenterology. 2007 Mar;54(74):359-63.PMID: 17523274 [PubMed - indexed for MEDLINE]Related articles

[Role of procalcitonin in the differentiation and surveillance of systemic inflammatory response syndrome]

Liu XL, Du B, Pan JQ, Xu Y, Hua BL.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2005 Feb;27(1):48-52. Chinese. PMID: 15782493 [PubMed - indexed for MEDLINE]Related articles

Reliability of procalcitonin as a severity marker in critically ill patients with inflammatory response.

Tugrul S, Esen F, Celebi S, Ozcan PE, Akinci O, Cakar N, Telci L.

Anaesth Intensive Care. 2002 Dec;30(6):747-54.PMID: 12500512 [PubMed - indexed for MEDLINE]Related articles